Ashland (Pharma)
Wilmington, DE · United States
Specialization: Polymers & Specialty Ingredients
Key Differentiator
NYSE: ASH; broad polymer portfolio enabling modified-release and ODT formulations; critical role in amorphous solid dispersion technology for poorly soluble drugs
Core Services
Klucel (HPC), Plasdone (PVP/VA), Benecel (HPMC), AquaSolve (HPMCAS for amorphous solid dispersions), Natrosol, solubility enhancement excipients, ODT platform
Capabilities
Market Intelligence
Sustained-release agents growing at 7.34% CAGR; oral solids = 48% of excipient demand (2024)
Website
https://ashland.comSimilar Companies
Avantor / J.T. Baker
Radnor, PA · High-Purity Chemicals & Excipients
NYSE: AVTR; $7.3B revenue; critical supplier of high-purity process chemicals to biopharma; opened advanced Dublin distribution center (Nov 2022)
Colorcon
Harleysville, PA · Film Coatings & Colorants
World leader in film coating systems; signed $740M 10-year deal with Lotte Fine Chemical for pharma cellulose (Oct 2024); global supply + application labs network
DFE Pharma
Toronto region, ON · Lactose & Inhalation Excipients
World leader in lactose-based excipients; Canadian distribution serving growing domestic pharma manufacturing sector
Roquette Canada
Various, QC/ON · Plant-Based Excipients
Partnered with Thermo Fisher (2018) for Canadian + US distribution; post-IFF acquisition creates dominant cellulose + mannitol supplier in Canada
Need help finding the right outsourcing partner?
Try AI NavigatorCompany information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.